留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

重要提示

《药学实践与服务》杂志不接收生物战剂、毒剂相关内容的稿件。对于涉军信息类论文如需投稿,请务必投稿前电话或邮箱咨询。联系电话:021-81871323,邮箱:yxsjzzs@163.com。敬请谅解,谢谢配合!

《药学实践与服务》编辑部

免责声明

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用,如收到邮件声称是编辑部X编辑,要求加作者微信的,请谨防财产损失!编辑部用于作者校稿时微信绑定的邮件是通过yxsjzzs@163.com发送的,标题是《药学实践与服务》XML数字出版服务微信绑定,请区分开!

网络药理学在中药作用机制中的研究进展

邢心睿 吕狄亚 柴逸峰 朱臻宇

邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
引用本文: 邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
Citation: XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001

网络药理学在中药作用机制中的研究进展

doi: 10.3969/j.issn.1006-0111.2018.02.001
基金项目: 国家自然科学基金(81773683)

Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method

  • 摘要: 网络药理学以系统生物学为基础,系统阐述了机体与药物相互作用的原理与规律,代表了现代生物医药的哲学理念与研究模式。运用网络药理学相关的技术手段,更便于理解中药治疗疾病的作用机制,目前网络药理学已被广泛应用于中药研究。从网络药理学及网络药理学应用等方面,介绍近年网络药理学在中药领域的运用与发展。
  • [1] Hopkins AL. Network pharmacology:the next paradigm in drug discovery[J]. Nat Chem Biol,2008,4(11), 682-690.
    [2] Fang J, Wang L, Wu T,et al. Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment[J]. J Ethnopharmacol,2017,196:281-292.
    [3] 李梢.网络靶标:中药方剂网络药理学研究的一个切入点[J].中国中药杂志,2011,36(15):2017-2020.
    [4] Yang M, Chen JL, Xu LW, et al. Navigating traditional chinese medicine network pharmacology and computational tools[J]. Evidence-based Complement Altern Med,2013, 2013:731969.
    [5] 薛潇春,胡晋红.网络药理学的研究方法与应用进展[J].药学实践杂志,2015,33(5):401-405.
    [6] 周文霞,王同兴,程肖蕊,等. 网络药理学研究中的网络构建技术[J].国际药学研究杂志,2016,43(5):791-812.
    [7] 何艳,于云莉,杨帆.基于复杂网络可视化的癫痫患者大脑状态研究[J]. 中国医疗设备,2016,31(9):39-42.
    [8] Lecca P, Re A. Network-oriented approaches to anticancer drug response[J]. Cancer Gene Networks,2016,03:101-117.
    [9] 周文霞,王同兴,程肖蕊,等.网络药理学研究中的网络分析技术[J].国际药学研究杂志,2016,43(3):399-409.
    [10] Li B,Xu X,Wang X, et al. A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease[J]. Int J Molecul Sci,2012,13(10):13501-13520.
    [11] Tao W, Xu X, Wang X, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].J Ethnopharmacol,2013, 145(1):1-10.
    [12] Li X, Wu L, Liu W, et al.A networkpharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action[J]. PloS ONE,2014, 9(5):e95004.
    [13] Fang HY, Zeng HW, Lin LM, et al. A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases[J]. Sci Rep, 2017,7:43632.
    [14] Hong M, Wang N,Feng Y,et al. A Biomedical investigation of the hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets[J]. Int J Molecul Sci,2017,18(3):620.
    [15] An L, Feng F.Network pharmacology-based antioxidant effect study of zhi-zi-da-huang decoction for alcoholic liver disease[J]. Evidence-based Complement Altern Med,2015,2015:492470.
    [16] Zhang B, Lu C, Bai M,et al.Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury[J]. J Ethnopharmacol,2015,175:638-647.
    [17] Wei S, Niu M, Wang J, et al.A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis[J]. Drug Design Development and Therapy,2016, 10:733-743.
    [18] van Berlo D,Hullmann M,Schins RP.Toxicology of ambient particulate matter[J]. Molecul, Clini Environment Toxicol,2012,101:165-217.
    [19] Yu G, Zhang Y, Ren W, et al.Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis[J]. In J Chron Obstruct Pulmon Dis,2017, 12:85-94.
    [20] Hou Y, Nie Y, Cheng B,et al.Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways[J]. Acta Pharmaceutica Sinica B,2016,6(3):212-221.
    [21] Tao J, Hou Y, Ma X,et al. An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica-Fritillaria usuriensis dropping pills for pulmonary diseases[J]. BMC Complement Altern Med,2016,16:4.
    [22] Xiang Z, Sun H, Cai X,et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology[J]. Molecular Biosystems, 2015,11(4):1067-1078.
    [23] Shi SH, Cai YP, Cai XJ, et al. A network pharmacology approach to understanding the mechanisms of action of traditional medicine:Bushenhuoxue formula for treatment of chronic kidney disease[J]. PloS ONE,2014,9(3):e89123.
    [24] Wang J,Yao K,Yang X,et al.Chinese patent medicineliu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension:a systematic review of randomized controlled trials[J]. Evidence-based Complement Altern Med, 2012, 2012:714805.
    [25] Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae:the Liu-Wei-Di-Huang pill as a case study[J]. Molecular Biosystems,2014,10(5):1014-1022.
    [26] Wang HH,Zhang BX,Ye XT, et al. Study on mechanism for anti-depression efficacy of Sini San through auxiliary mechanism elucidation system for Chinese medicine[J]. Zhongguo Zhong Yao Za Zhi,2015,40(19):3723-3728.
    [27] Margineanu DG. Systems biology, complexity, and the impact on antiepileptic drug discovery[J]. Epilepsy Behav,2014,38:131-142.
    [28] Guo Q, Mao X, Zhang Y,et al. Guizhi-Shaoyao-Zhimu decoction attenuates rheumatoid arthritis partially by reversing inflammation-immune system imbalance[J]. J Transl Med, 2016,14(1):165.
    [29] Zhang Y, Wang D, Tan S, et al. A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis[J]. Evidence-based Complement Altern Med,2013,2013:548498.
    [30] Zhang Y, Mao X, Guo Q, et al. Pathway of PPAR-gamma coactivators in thermogenesis:a pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis[J]. Oncotarget,2016,7(13):15885-15900.
    [31] Chen Y, Palczewski K. Systems pharmacology links GPCRs with retinal degenerative disorders[J]. Ann Rev Pharmacol Toxicol,2016,56:273-298.
    [32] Liu H, Zeng L, Yang K. A network pharmacology approach to explore the pharmacological mechanism of Xiaoyao powder on anovulatory infertility[J]. Evidence-based Complement Altern Med,2016,2016:1-13.
    [33] Tang F, Tang Q, Tian Y,et al. Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis[J]. J Ethnopharmacol,2015,176:402-412.
  • [1] 刘彬果, 吴葆婷, 王剑丽, 陈竹卿.  中药防治流感病毒性肺炎的作用及机制研究进展 . 药学实践与服务, 2025, 43(11): 540-547. doi: 10.12206/j.issn.2097-2024.202402033
    [2] 杨金润, 黎翔, 孙旸.  ORM1促肝细胞增殖的作用及其机制探索 . 药学实践与服务, 2025, 43(5): 222-227. doi: 10.12206/j.issn.2097-2024.202410014
    [3] 周文艳, 胡珊珊, 张万年, 庄春林.  Keap1-Nrf2通路在炎症疾病中的研究进展 . 药学实践与服务, 2025, 43(3): 97-108, 116. doi: 10.12206/j.issn.2097-2024.202405013
    [4] 王新霞, 刘祉君, 吕磊, 张爽, 高守红.  鬼针草降压作用研究及展望 . 药学实践与服务, 2025, 43(9): 427-430. doi: 10.12206/j.issn.2097-2024.202408021
    [5] 晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英.  基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
    [6] 王晓松, 刘云娇, 周瑾, 张倩倩, 孟令杰.  达拉非尼联合曲美布单抗对黑色素瘤的治疗作用及机制研究 . 药学实践与服务, 2025, 43(10): 496-502. doi: 10.12206/j.issn.2097-2024.202504070
    [7] 张紫璇, 高苑, 张利, 李佳莉, 徐希科, 祖先鹏.  中药防治急性肺损伤的活性成分及其作用机制研究进展 . 药学实践与服务, 2025, 43(9): 421-426, 474. doi: 10.12206/j.issn.2097-2024.202404079
    [8] 杨延涛, 郁超, 张志航, 潘宇炯, 何晓锋, 林敬宇, 李明智, 孙佳烨, 徐敏.  基于网络药理学、分子对接技术及体外实验验证探究健复饮治疗勃起功能障碍的作用机制 . 药学实践与服务, 2025, 43(): 1-10. doi: 10.12206/j.issn.2097-2024.202407013
    [9] 柯刚, 董清科, 肖世容, 龚茜, 李荣, 汪代杰.  基于网络药理学探讨参苓白术散治疗肿瘤恶病质的作用机制 . 药学实践与服务, 2025, 43(5): 242-250. doi: 10.12206/j.issn.2097-2024.202208115
    [10] 闻韬, 焦广洋, 赵梦沛, 岳小强, 张凤, 陈万生.  基于UHPLC-Q-TOF/MS结合网络药理学研究柴胡桂枝干姜汤治疗慢性非萎缩性胃炎的物质基础及疗效机制 . 药学实践与服务, 2025, 43(9): 455-462. doi: 10.12206/j.issn.2097-2024.202312061
    [11] 徐璐璐, 刘爱军.  丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2025, 43(3): 143-150. doi: 10.12206/j.issn.2097-2024.202312027
    [12] 张霖峰, 孙宇恒, 王冬尧, 李丹, 曹岩, 吕狄亚.  茵陈蒿汤体内成分分析及其抗肝癌作用机制的网络药理学研究 . 药学实践与服务, 2025, 43(): 1-9. doi: 10.12206/j.issn.2097-2024.202501017
    [13] 张强, 李静, 刘越, 储晓琴.  基于网络药理学与分子对接技术研究制痂酊治疗度烧伤的作用机制 . 药学实践与服务, 2025, 43(8): 377-382, 399. doi: 10.12206/j.issn.2097-2024.202307014
    [14] 胡越, 殷勇, 徐晓红, 施柳辉, 朱建勇, 年华.  基于网络药理学探讨夏枯草消瘤合剂治疗非小细胞肺癌的作用机制 . 药学实践与服务, 2025, 43(12): 1-8. doi: 10.12206/j.issn.2097-2024.202302020
    [15] 李清, 郭宜银, 陈颖, 瞿发林, 董文燊, 戈煜.  夜宁胶囊对小鼠镇静催眠作用及其机制的研究 . 药学实践与服务, 2024, 42(8): 346-349. doi: 10.12206/j.issn.2097-2024.202211047
    [16] 张林晨, 张小琴, 张俊平.  山楂酸药理作用的研究进展 . 药学实践与服务, 2024, 42(5): 185-189. doi: 10.12206/j.issn.2097-2024.202307052
    [17] 张成中, 朱雪艳, 卜其涛, 王宏瑞, 黄宝康.  基于网络药理学与分子对接预测鸡骨草特征图谱研究 . 药学实践与服务, 2024, 42(8): 350-358. doi: 10.12206/j.issn.2097-2024.202303048
    [18] 陈金涛, 乔子婴, 马明华, 张若曦, 王振伟, 年华.  基于网络药理学和分子对接技术研究金芪清疏颗粒治疗社区获得性肺炎的潜在机制 . 药学实践与服务, 2024, 42(11): 471-478. doi: 10.12206/j.issn.2097-2024.202312014
    [19] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
    [20] 陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾.  基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
  • 加载中
计量
  • 文章访问数:  11307
  • HTML全文浏览量:  1701
  • PDF下载量:  1280
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-09-11
  • 修回日期:  2017-11-03

网络药理学在中药作用机制中的研究进展

doi: 10.3969/j.issn.1006-0111.2018.02.001
    基金项目:  国家自然科学基金(81773683)

摘要: 网络药理学以系统生物学为基础,系统阐述了机体与药物相互作用的原理与规律,代表了现代生物医药的哲学理念与研究模式。运用网络药理学相关的技术手段,更便于理解中药治疗疾病的作用机制,目前网络药理学已被广泛应用于中药研究。从网络药理学及网络药理学应用等方面,介绍近年网络药理学在中药领域的运用与发展。

English Abstract

邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
引用本文: 邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
Citation: XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
参考文献 (33)

目录

    /

    返回文章
    返回